567 results on '"Sławek, Jarosław"'
Search Results
2. 2-Methoxyestradiol and Hydrogen Peroxide as Promising Biomarkers in Parkinson’s Disease
3. Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review
4. Sex contribution to average age at onset of Huntington’s disease depends on the number of (CAG)n repeats
5. Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
6. A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
7. Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study
8. Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus
9. The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease
10. The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning
11. Sex contribution to average age at onset of Huntington’s disease depends on the number of (CAG)n repeats.
12. An expert opinion of the Heart Rhythm Section of the Polish Cardiac Society and professionals from the Polish Neurological Society on evidence-driven implementation of implantable loop recorders in Poland
13. Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
14. Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease.
15. Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus.
16. Expert opinion of the Heart Rhythm Association of the Polish Cardiac Society and the Polish Neurological Society on evidence-driven implementation of implantable loop recorders in Poland.
17. Computer Aided Feature Extraction in the Paper Version of Luria’s Alternating Series Test in Progressive Supranuclear Palsy
18. Cognitive and behavioral profile of Perry syndrome in two families
19. Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks
20. Choroba Fabry'ego — dlaczego warto ją poznać?
21. The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease
22. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
23. Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study
24. Dokanałowe podawanie baklofenu w leczeniu nasilonej spastyczności segmentalnej i uogólnionej -- rekomendacje interdyscyplinarnej grupy ekspertów.
25. Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’
26. Latest bibliometrics of Polish Journal of Neurology and Neurosurgery
27. 2-Methoxyestradiol and Hydrogen Peroxide as Promising Biomarkers in Parkinson’s Disease
28. First families with spinocerebellar ataxia type 7 in Poland
29. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
30. An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group
31. Perry disease – expanding the genetic basis
32. Acute/subacutae demyelinating polyneuropathy in Parkinson’s Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report
33. DCTN1-related neurodegeneration: Perry syndrome and beyond
34. Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination — an update
35. Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines
36. Journal’s Leading Topics & Thank You to Our Reviewers
37. Post– COVID ‐19 Myoclonus–Ataxia Syndrome – is there really a need for intravenous immunoglobulin treatment in all cases?
38. Toksyna botulinowa w spastyczności o różnej etiologii — rekomendacje interdyscyplinarnej grupy ekspertów
39. A Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes
40. First report on spinocerebellar ataxia type 3 (Machado–Joseph disease) in Poland
41. Computer Aided Feature Extraction in the Paper Version of Luria’s Alternating Series Test in Progressive Supranuclear Palsy
42. Leczenie zaawansowanej choroby Parkinsona -- rekomendacje Polskiego Towarzystwa Choroby Parkinsona i Innych Zaburzeń Ruchowych (2023).
43. Sleep disorders in Parkinson's disease
44. Overlapping and distinguishing features of descriptive speech in Richardson variant of progressive supranuclear palsy and non-fluent progressive aphasia
45. Single-photon emission computed tomography in the differential diagnosis of dementia with Lewy Bodies
46. Choroba Parkinsona — słowa „klucze” do rozpoznania i efektywnego leczenia
47. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study)
48. H36 Does performance of the 9 Hole Peg test improve awareness of motor impairment in Huntington’s disease patients?
49. Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study
50. Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.